Fisher Clinical Services, Inc. has applied to the Drug Enforcement Administration to be registered as an importer of certain controlled substances. The purpose of this registration is solely for use in clinical trials, and not for the commercial sale of the substances. The public can submit comments or request a hearing about this application until April 14, 2025. Comments must be submitted electronically, and hearings can be requested in writing, with specific addresses provided for these submissions.
Simple Explanation
Fisher Clinical Services wants permission from the government to bring special medicines into the country, but only to use them for testing, not selling. People have time until April 14, 2025, to tell the government what they think about this or ask for a chat about it.